SEC Form 4

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION						
Washington, D.C. 20549						
		OMB APPROVAL		
				
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP						
		OMB Number:	3235-0287			
		Estimated average burden		
				
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934		hours per response:	0.5			

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*
Medpace Investors, LLC

(Last)	(First)	(Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)			
	CINCINNATI	OH	45227	
				
	(City)	(State)	(Zip)	

2.	Issuer Name and Ticker or Trading Symbol	5.	Relationship of Reporting Person(s) to Issuer		
	Medpace Holdings, Inc. [ MEDP ]	(Check all applicable)			
							
					Director	X   10% Owner		
								
3.	Date of Earliest Transaction (Month/Day/Year)		Officer (give title	Other (specify		
04/25/2023			below)	below)		
							
4.	If Amendment, Date of Original Filed (Month/Day/Year)	6.	Individual or Joint/Group Filing (Check Applicable		
Line)

X	Form filed by One Reporting Person

Form filed by More than One Reporting

Person

Rule 10b5-1(c) Transaction Indication

X	Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

	1. Title of Security (Instr. 3)	2. Transaction	2A. Deemed	3.	4. Securities Acquired (A) or		5. Amount of	6. Ownership	7. Nature		
				Date		Execution Date,	Transaction	Disposed Of (D) (Instr. 3, 4 and 5)	Securities	Form: Direct	of Indirect		
				(Month/Day/Year)	if any			Code (Instr.						Beneficially	(D) or Indirect	Beneficial		
						(Month/Day/Year)	8)						Owned Following	(I) (Instr. 4)	Ownership		
															Reported		(Instr. 4)		
																			
									Code  V	Amount	(A) or	Price		Transaction(s)						
											(D)			(Instr. 3 and 4)						

	Common Stock		04/25/2023				S(1)	31,648	D	$221.83(2)	6,451,371	D					
			Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned						
				(e.g., puts, calls, warrants, options, convertible securities)									
															
	1. Title of	2.	3. Transaction	3A. Deemed	4.		5. Number	6. Date Exercisable and	7. Title and	8. Price of	9. Number of    10.	11. Nature		
	Derivative	Conversion	Date	Execution Date,	Transaction	of	Expiration Date	Amount of	Derivative	derivative	Ownership	of Indirect		
	Security	or Exercise	(Month/Day/Year)	if any	Code (Instr.	Derivative	(Month/Day/Year)	Securities	Security	Securities	Form:	Beneficial		
	(Instr. 3)	Price of		(Month/Day/Year)	8)		Securities			Underlying	(Instr. 5)	Beneficially	Direct (D)	Ownership		
		Derivative					Acquired			Derivative			Owned	or Indirect	(Instr. 4)		
		Security					(A) or			Security (Instr.			Following	(I) (Instr. 4)					
							Disposed			3 and 4)			Reported						
							of (D)								Transaction(s)					
							(Instr. 3, 4								(Instr. 4)						
							and 5)														
																						
												Amount									
												or									
												Number									
									Date	Expiration		of									
					Code	V	(A)   (D)	Exercisable	Date	Title	Shares									

Explanation of Responses:

1.	The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2023.

2.	The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $230.94. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.

/s/ Stephen P. Ewald,

Authorized Signatory for	04/27/2023

Medpace Investors, LLC

** Signature of Reporting Person	Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.